MRPS31 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.29780647234656E-12 |
Normal-vs-Stage2 |
5.018500E-03 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
2.785000E-01 |
Stage1-vs-Stage3 |
2.33709999999387E-05 |
Stage1-vs-Stage4 |
1.399800E-04 |
Stage2-vs-Stage3 |
3.217300E-03 |
Stage2-vs-Stage4 |
3.299000E-03 |
Stage3-vs-Stage4 |
8.590600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
1.63890012672141E-10 |
Normal-vs-Asian |
5.70359999999548E-05 |
Caucasian-vs-AfricanAmerican |
8.593800E-01 |
Caucasian-vs-Asian |
5.356400E-01 |
AfricanAmerican-vs-Asian |
5.522000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.97880001273631E-09 |
Male-vs-Female |
9.52539999999891E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.74632999999647E-05 |
Normal-vs-Age(41-60Yrs) |
6.88338275267597E-15 |
Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(81-100Yrs) |
1.54869999999807E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.917200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.828400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.774600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.853200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.607000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.987590E-01 |
Normal-vs-Grade 2 |
2.36380004459136E-09 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.619740E-02 |
Grade 1-vs-Grade 3 |
5.181600E-04 |
Grade 1-vs-Grade 4 |
2.79309999573485E-08 |
Grade 2-vs-Grade 3 |
4.82869999995916E-06 |
Grade 2-vs-Grade 4 |
3.99857924548996E-12 |
Grade 3-vs-Grade 4 |
4.772800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.97309999996997E-06 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62703184258817E-12 |
Normal-vs-N1 |
2.12529993603994E-10 |
N0-vs-N1 |
6.332000E-02 |
|
|